Literature DB >> 32745181

A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.

Lianna Goetz1, Jianbo Yang1, Wallace Greene1, Yusheng Zhu1.   

Abstract

Entities:  

Keywords:  antibody; chronic lymphocytic leukemia; coronavirus disease -19 (COVID-19); immunodeficiency; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Mesh:

Substances:

Year:  2020        PMID: 32745181      PMCID: PMC7454661          DOI: 10.1093/jalm/jfaa137

Source DB:  PubMed          Journal:  J Appl Lab Med        ISSN: 2475-7241


× No keyword cloud information.
  5 in total

1.  Venetoclax Decreases the Expression of the Spike Protein through Amino Acids Q493 and S494 in SARS-CoV-2.

Authors:  Chih-Chieh Chen; Zhi-Jie Zhuang; Chia-Wei Wu; Yi-Ling Tan; Chen-Hsiu Huang; Chia-Yi Hsu; Eing-Mei Tsai; Tsung-Hua Hsieh
Journal:  Cells       Date:  2022-06-14       Impact factor: 7.666

Review 2.  Preoperative assessment for scheduling surgery during the coronavirus disease pandemic.

Authors:  Koichi Suehiro
Journal:  J Anesth       Date:  2021-01-27       Impact factor: 2.078

3.  Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies.

Authors:  Kay Weng Choy
Journal:  Lancet Infect Dis       Date:  2020-10-30       Impact factor: 25.071

Review 4.  Molecular detection of SARS-CoV-2 being challenged by virus variation and asymptomatic infection.

Authors:  Congshan Jiang; Xiaowei Li; Changrong Ge; Yuanyuan Ding; Tao Zhang; Shuai Cao; Liesu Meng; Shemin Lu
Journal:  J Pharm Anal       Date:  2021-03-26

5.  Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency.

Authors:  Samaneh Delavari; Hassan Abolhassani; Farhad Abolnezhadian; Fateme Babaha; Sara Iranparast; Hamid Ahanchian; Nasrin Moazzen; Mohammad Nabavi; Saba Arshi; Morteza Fallahpour; Mohammad Hassan Bemanian; Sima Shokri; Tooba Momen; Mahnaz Sadeghi-Shabestari; Rasol Molatefi; Afshin Shirkani; Ahmad Vosughimotlagh; Molood Safarirad; Meisam Sharifzadeh; Salar Pashangzadeh; Fereshte Salami; Paniz Shirmast; Arezou Rezaei; Tannaz Moeini Shad; Minoo Mohraz; Nima Rezaei; Lennart Hammarström; Reza Yazdani; Asghar Aghamohamamdi
Journal:  J Clin Immunol       Date:  2020-12-01       Impact factor: 8.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.